Compare United States Brent Oil Fund LP (BNO) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
United States Brent Oil Fund LP vs Revvity Inc — how do they compare? United States Brent Oil Fund LP trades at $50.85, while Revvity Inc trades at $116.16 (market cap $12.91B). The key difference: Revvity Inc pays a 0.24% dividend while United States Brent Oil Fund LP pays none, and Revvity Inc is trading nearer its 52-week high, United States Brent Oil Fund LP nearer its low. Which is the better fit depends on your goals.
| BNO | RVTY | |
|---|---|---|
Sector | Commodities - Energy | Technology |
52-Week High | $60.13 | $117.75 |
52-Week Low | $27.20 | $82.26 |
Market Cap | — | $12.91B |
Enterprise Value | — | $15.23B |
Dividend Yield | — | 0.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BNO, tracking Brent crude oil futures, trades at $50.73, up 1.24% today, with a bullish technical signal from moving averages and neutral oscillators. Recent news highlights supply disruptions from the Strait of Hormuz standoff and OPEC's lowered demand forecasts, creating volatility. The stock lacks traditional financial ratios as it is an ETF, with performance tied directly to oil price movements and geopolitical developments.
Outlook hinges on oil market dynamics, with upside from sustained supply risks but downside from demand weakness. Risks include Middle East tensions and inventory builds. Analysts monitor EIA data and OPEC actions for direction, with current sentiment mixed amid headline-driven price swings.
RVTY trades at $116.10, up 0.07% on the day, with a bullish technical signal and strong earnings beats in recent quarters. The company reported Q2 2026 EPS of $1.41, surpassing the $1.21 estimate, and raised its full-year outlook due to robust diagnostics demand. Revenue remains steady around $2.9 billion, with a net income margin of 8.16%. Analyst consensus is a Buy with a $120.50 price target, and recent news highlights product launches like the SuperFlex prenatal system and high-throughput TB testing platform.
The outlook for RVTY is positive, supported by earnings momentum and strategic innovations, but investors face risks from high valuation multiples and competitive pressures in the healthcare sector. The stock's proximity to its consensus target suggests limited near-term upside, requiring careful monitoring of execution against raised guidance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About United States Brent Oil Fund LP
BNO is a commodity ETF that tracks the daily price of Brent crude oil futures. It provides exposure to the international oil benchmark, which often trades at a premium to the U.S. WTI benchmark, and is primarily used for short-term trading due to roll costs.
Read more on BNO →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
